ZEB1 knockdown alone was as efficient as vemurafenib treatment in decreasing SKMEL5 xenografted tumor growth, but the combined inhibition of BRAF and ZEB1 did not lead to a further significant decrease in tumor growth (Fig EV4D). This evidence concerns the gene BRAF and neoplasm.